Mike Boyer
Investor Relations
Replay available
Rapid Micro Biosystems, Inc. (NASDAQ: RPID) Q4 2025 earnings conference call, held 2026-03-12. Replay captured from the company's public earnings webcast.

Investor Relations
President and Chief Executive Officer
Chief Financial Officer
Analyst, Lake Street Capital Markets
Analyst, Steve Foley
Analyst, KeyBank
Analyst, TD Cowen
Good day and thank you for standing by. Welcome to the Rapid Microbiosystems fourth quarter and full year 2025 earnings conference call. At this time, all participants are on listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please advise that today's conference is being recorded. I would like to hand the conference over to your first speaker today, Mike Boyer of Investor Relations. Please go ahead. Good morning, and thank you for joining the Rapid Microbiosystems fourth quarter and full year 2025 earnings call. Joining me on the call are Rob Spignessi, President and Chief Executive Officer, and Sean Wurchis, Chief Financial Officer. Earlier today, we issued a press release announcing our fourth quarter and full year 2025 financial results. A copy of the release is available on the company's website at rapidmicrobio.com under Investors in the News and Events section. Before we begin, I'd like to remind you that many statements made during this call may be considered forward-looking statements within the meaning of federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements including, but not limited to, statements relating to Rapid Micro's financial condition, assumptions regarding future financial performance, anticipated future cash usage, statements relating to the company's term loan...